Now live: Pro — the full 13F research suite for serious investorsSee pricing →
First Light Asset Management, LLC

Q1 2024 · 13F-HR

First Light Asset Management, LLCholdings as filed

Filed 2024-05-15 · accession 0001999371-24-006153

$1.31B
Reported value
50
Positions
2024-03-31
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
22663K107CRNXCRINETICS PHARMACEUTICALS INC$79.1M6.06%1,690,177CommonSOLE
02081G201ATECALPHATEC HOLDINGS INC$74.7M5.72%5,418,631CommonSOLE
632307104NTRANATERA INC$60.1M4.60%656,708CommonSOLE
98420N105XENEXENON PHARMACEUTICALS$56.8M4.35%1,320,172CommonSOLE
729139105PLRXPLIANT THERAPEUTICS INC$52.7M4.03%3,534,993CommonSOLE
89377M109TMDXTRANSMEDICS GROUP INC$52.6M4.03%711,682CommonSOLE
82489T104SWAVUSDSHOCKWAVE MEDICAL INC$52.6M4.03%161,484CommonSOLE
64049M209NEONEOGENOMICS INC$51.9M3.97%3,302,165CommonSOLE
450056106IRTCIRHYTHM TECHNOLOGIES$48.8M3.74%420,892CommonSOLE
69913P105FNAUSDPARAGON 28 INC$47.0M3.60%3,802,968CommonSOLE
87357P100TCMDTACTILE SYSTEMS TECHNOLOGY INC$42.9M3.29%2,641,975CommonSOLE
04963C209ATRCATRICURE INC$42.1M3.22%1,382,860CommonSOLE
825704109SIBNSI-BONE INC$40.5M3.10%2,473,165CommonSOLE
90400D108RAREULTRAGENYX PHARMACEUTICAL INC$36.9M2.83%790,446CommonSOLE
152309100CNTACENTESSA PHARMACEUTICALS LIMITED$33.9M2.60%3,002,045CommonSOLE
77634L105RCM1USDR1 RCM INC$32.9M2.52%2,552,325CommonSOLE
687793109OSCROSCAR HEALTH INC CLASS A$31.3M2.39%2,102,554CommonSOLE
71377E105PFMTUSDPERFORMANT FINANCIAL CORPORATION$30.9M2.37%10,515,127CommonSOLE
457730109INSPINSPIRE MEDICAL SYSTEMS INC$30.1M2.30%139,951CommonSOLE
088786108BCYCBICYCLE THERAPEUTICS PLC$29.7M2.27%1,193,051CommonSOLE
T9224W109STVNSTEVANATO GROUP SPA$26.8M2.05%835,985CommonSOLE
45784P101PODDINSULET CORP$25.9M1.99%151,264CommonSOLE
607525102MODNEURMODEL N INC$25.5M1.95%894,241CommonSOLE
05352A100AVTRAVANTOR INC$21.8M1.67%850,695CommonSOLE
74276R102PRVAPRIVIA HEALTH GROUP INC$21.6M1.66%1,103,601CommonSOLE
032724106ANABANAPTYS BIO INC$21.3M1.63%944,110CommonSOLE
75629F109RAHSOCIETAL CDMO INC$21.3M1.63%19,676,396CommonSOLE
68401U204OPRXOPTIMIZERX CORP$21.1M1.62%1,737,584CommonSOLE
02083G100NVLSEURALPINE IMMUNE SCIENCES INC$19.9M1.52%501,243CommonSOLE
92337R101VERAVERA THERAPEUTICS INC$18.8M1.44%436,133CommonSOLE
875372203TNDMTANDEM DIABETES CARE INC$16.8M1.29%475,077CommonSOLE
872381108TELATELA BIO INC$15.6M1.20%2,754,028CommonSOLE
45166A102IDYAIDEAYA BIOSCIENCES INC$14.7M1.13%335,471CommonSOLE
759910102KRMDKORU MEDICAL SYSTEMS INC$12.3M0.94%5,220,990CommonSOLE
G72800108PRTAPROTHENA CORPORATION PLC$11.0M0.84%444,953CommonSOLE
45332Y109NARIUSDINARI MEDICAL INC.$10.3M0.79%213,940CommonSOLE
30050B101EVHEVOLENT HEALTH INC$9.4M0.72%288,181CommonSOLE
70975L107PENPENUMBRA, INC.$8.5M0.65%37,955CommonSOLE
88033G407THCTENET HEALTHCARE CORP$8.4M0.64%79,523CommonSOLE
457669307INSMINSMED INC$7.7M0.59%282,766CommonSOLE
86366E106GPCRSTRUCTURE THERAPEUTICS INC$6.4M0.49%149,113CommonSOLE
05463X106AXGNAXOGEN INC$6.2M0.47%765,886CommonSOLE
G5509L101LIVNLIVANOVA PLC$5.8M0.44%102,792CommonSOLE
42225T107HCATHEALTH CATALYST INC$5.5M0.42%734,681CommonSOLE
92243G108PCVXVAXCYTE INC$4.1M0.32%60,284CommonSOLE
40131M109GHGUARDANT HEALTH$3.9M0.30%189,765CommonSOLE
92332V107VTYXUSDVENTYX BIOSCIENCES INC$3.4M0.26%624,842CommonSOLE
26818M108DYNDYNE THERAPEUTICS INC$3.0M0.23%105,948CommonSOLE
829214105SLPSIMULATIONS PLUS INC$1.2M0.09%28,741CommonSOLE
835431107SONENDO INC$544,7090.04%5,143,615CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.